Skip to main content
. 2021 Sep 12;2021(9):CD011612. doi: 10.1002/14651858.CD011612.pub3

Comparison 15. Basimglurant versus Placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
15.1 Response rate 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
15.1.1 at 4 weeks 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
15.2 AE Dizziness 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
15.3 AE Dry mouth 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
15.4 AE Fatigue 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
15.5 AE Headache 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
15.6 AE Insomnia 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
15.7 AE Nasopharyngitis 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
15.8 AE Nausea 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
15.9 Remission rate 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
15.9.1 at 4 weeks 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
15.10 Depression rating scale score 1   Mean Difference (IV, Random, 95% CI) Totals not selected
15.10.1 at 4 weeks 1   Mean Difference (IV, Random, 95% CI) Totals not selected